INDIGENOUS AUSTRALIAN HEALTH AND EAR DISEASE
Professor Kelvin Kong AM, Royal Australasian College of Surgeons Fellow Otolaryngology, Head and Neck Surgeon Worimi Nation, Australia &
School of Medicine and Public Health, University of Newcastle, Australia &
Honorary Professor, Macquarie University &
Adjunct Professor, University of NSW, Australia
RESEARCHER PROFILE
Filmed in Newcastle, NSW, Australia | October 2025
Professor Kelvin Kong feels incredibly fortunate to lead a fulfilling life surrounded by his loved ones. With a demonstrated history of service in the health industry, he brings a wealth of expertise across various sectors including clinical research, medical education, surgery, paediatrics, health policy, and Indigenous education. Kelvin started his university, residing at New College in 1992, which brings him fond memories. Graduating from medicine from the University of NSW, Kelvin continued his studies and became a fellow of the Royal Australasian College of Surgeons (RACS) and Australian Society of Otolaryngology, head & neck Society (ASOHNS).
Based in Newcastle on Awabakal and Worimi Country, Kelvin specialises in Paediatric & Adult Otolaryngology, Head & Neck Surgery. His practice encompasses a diverse range of adult and paediatric patients, with a particular interest in Paediatric Airway and Cochlear Implantation.
Beyond his clinical work, Kelvin is deeply committed to community service. His dedication to improving health outcomes extends to his role as a Professor at the University of Newcastle’s School of Medicine and Public Health, as well as his Honorary Professorships at Macquarie University and Associate Professorships UNSW. He established the Muku (Ear) Indigenous Ear Research program and strongly involved in many facets of research, particularly in relation to engaging community in research and creating career pathways. He is the senior examiner of the ORL Mini-court for RACS and member of the National Ear and Hearing Health Partnership Committee to highlight a few.
Hailing from the Worimi people of Port Stephens, NSW, Kelvin’s heritage informs his passion for health and education improvement initiatives. He remains grounded by the support of his family, who continue to inspire him in his efforts to give back to the community. Through his advocacy, research, and clinical practice, Kelvin strives to make a positive impact on the lives of others, guided by his commitment to equity and the well-being of all.
Source: Supplied
https://orcid.org/0000-0002-8384-0149
-
Applying nanotechnology to chronic pain management
Dr Felicity Han is a Research Fellow and Leader in Pain Relief Innovation, at the Australian Institute for Bioengineering and Nanotechnology in the University of Queensland. Dr Han’s research interests sit at the interface of drug delivery and the pain field. Her overarching research goal is to improve the quality of day to day life of patients suffering from chronic pain, by applying nanotechnology to the development of novel highly effective pain-killer products for improving chronic pain management.
-
Paediatric haemorrhage and airway procedures
Dr Shane George is a paediatric critical care physician working in paediatric emergency medicine and paediatric intensive care at Gold Coast University Hospital. He is the clinical lead for children’s critical care research for Gold Coast Health, and is a Senior Lecturer at The University of Queensland and Griffith University.
Associate Professor George is also an active clinician researcher on topics that span both emergency medicine and PICU practice including safety in emergency intubation, sepsis, haemostatic resuscitation in children and respiratory support therapies.
-
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.
